DP076 | TOLERABILITY AND EFFICACY OF “CARMEN” AND OTHER INTENSIFIED REGIMENS USED IN HIV-NEGATIVE AND HIV-POSITIVE PATIENTS WITH BURKITT LYMPHOMA: REAL-LIFE DATA FROM A MULTICENTER SERIES OF 153 PATIENTS

Introduction: Treatment for sporadic and HIV-associated BL involves resource-heavy regimens, with long delivery times, often dose-limiting toxicity, and increased TRM. Over the last decades, BL pts have been successfully treated with the dose-dense, short-term “CARMEN” therapy in Italian Centres. C...

Full description

Bibliographic Details
Published in:Haematologica
Main Authors: P. Angelillo, F. Erbella, C. Pagani, E. Ravano, L. Verga, F. Cavallo, M.C. Quattrocchi, P. Fiore, C. Cattaneo, G. Rindone, E. Amaducci, F. Pagni, L. Bandiera, L. Pecciarini, A. Passi, S. Maifredi, L. Lorenzi, L. BonG., T. Calimeri, E. Flospergher, F. Marino, G. Cassanello, S. Marktel, S. Mastaglio, F. Palumbo, L. Saliani, M. Quattrone, M. Ponzoni, M. Spina, A. Re, A.J.M. Ferreri
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-09-01
Online Access:https://haematologica.org/article/view/12740